Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX-A injection site comparison in post-stroke spasticity
NCT01278576Phase 4Completed
- Sponsor
- The Catholic University of Korea
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of onabotulinumtoxinA in Spasticity, sponsored by The Catholic University of Korea. Primary endpoint: Electromyogram activity at 8 weeks. Started Jan 2011; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT01278576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278576.